Haystack Oncology Funding: $56M Raised, Series A (2022)
Haystack Oncology is based in Baltimore, MD. It has raised $56M in total funding. Latest round: Series A.
Haystack Oncology funding overview
Haystack Oncology is based in Baltimore, MD. Haystack Oncology has raised $56M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in November 2022. The round record for Haystack Oncology runs through 2022; nothing later has been disclosed. Investors on record include Catalio Capital Management, Bruker, Exact Ventures, Alexandria Venture Investments. 4 distinct backers are named across the disclosed rounds.
Haystack Oncology at a glance
Total raised
$56M
Latest round
Series A
Latest round date
November 2022
Headquarters
Baltimore, MD
Notable investors
Catalio Capital Management, Bruker, Exact Ventures, Alexandria Venture Investments
Frequently asked about Haystack Oncology funding
How much has Haystack Oncology raised?
Haystack Oncology has raised $56M in total disclosed funding across the rounds on record.
Who has invested in Haystack Oncology?
Catalio Capital Management, Bruker, Exact Ventures, Alexandria Venture Investments are named among the investors backing Haystack Oncology.
What was the latest Haystack Oncology funding round?
The most recent disclosed round is a Series A, announced in November 2022.
Where is Haystack Oncology based?
Haystack Oncology is based in Baltimore, MD.
When did Haystack Oncology last raise?
The last disclosed Haystack Oncology round closed in November 2022 at Series A.
Totals shown for Haystack Oncology aggregate every disclosed round on file. To see how that compares, browse the companies in Baltimore and the investors behind them below.
